The Next Era of Vaccine Governance with Dorit Reiss, Part 1

The Next Era of Vaccine Governance with Dorit Reiss, Part 2

Why today's measles resurgence is different than prior ones and why that should change how we respond

The vaccine conversation no longer begins in the examination room. Many parents come with fear and confusion that is shaped long before the visit by social media, political rhetoric, and, increasingly...

Here's a guide to help you stay informed and talk about it

RFK Jr. and the CDC’s top official, Dr. Jay Bhattacharya, don’t want you to read this. That’s exactly why you should.

Why a Politico headline overstated vaccine scepticism in the US

The report, which had cleared the agency’s scientific-review process, had been delayed. It now won’t be published at all, people familiar with the decision told The Post.

Vaccination programs in the U.S. military date back to the American Revolution, but they became a contentious political issue during the coronavirus pandemic.

Despite some headlines, a new poll does not show that most Americans no longer trust vaccines.

Despite some headlines, a new poll does not show that most Americans no longer trust vaccines.

What vaccine-hesitant parents are told, what pediatricians are actually doing, and the legislation caught in between

Unbiased Science · Episode

The most effective vaccine program in American history doesn’t require a single new drug, clinical trial, or breakthrough.

Vaccine critics like to say that pediatricians profit from vaccines. This report found something very different.

And why a little-known commission, a severe flu season, and a hepatitis B vaccine study in Africa deserve attention

The consequences of rewriting the pediatric vaccine schedule

The plan, which is not finalized, suggests children get fewer shots and shifts to a model telling parents to consult doctors to make their own vaccine choices.

HHS cuts key AAP grants, citing concerns about “identity-based language” and insufficient focus on agency priorities. The organization said the cuts could harm child health.

If there is a misperception about high rates of vaccine hesitancy in patients, that creates risk at the policy level and at the physician level. David Higgins, MD, MPH, FAAP, explains.

The decision undoes a highly effective 34-year prevention strategy that has nearly eliminated early childhood hepatitis B infections in the U.S.